<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00792428</url>
  </required_header>
  <id_info>
    <org_study_id>2005P000346</org_study_id>
    <secondary_id>R01NS045049</secondary_id>
    <nct_id>NCT00792428</nct_id>
  </id_info>
  <brief_title>Non-invasive Brain Stimulation and Occupational Therapy To Enhance Stroke Recovery</brief_title>
  <acronym>TDCS+OT</acronym>
  <official_title>Facilitating Motor Recovery After Stroke Using tDCS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Beth Israel Deaconess Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a non-painful, non-invasive,
      brain-stimulation technique called transcranial direct current stimulation (tDCS) combined
      with traditional physical-occupational therapy (OT) will improve motor function in patients
      with chronic stroke. The aim is to determine the effect of applying real (anodal and/or
      cathodal) - in a dual configuration - vs sham (pretend) tDCS to the motor brain regions on
      both hemispheres - in a dual configuration - to improve motor function in chronic stroke
      patients. Our research in normal subjects has shown that motor skills can be enhanced if tDCS
      is applied to the brain's motor region during motor learning. The effects after a single
      session of tDCS can last for up to 30 minutes, effects of multiple sessions (one session per
      day) can last for weeks. Furthermore, single sessions of tDCS applied to the motor regions in
      stroke patients have shown that improvements in motor functions can be seen and that effects
      may last for at least 30 minutes. Patients enrolled in this trial will be randomized to
      receive either real tDCS or sham tDCS in combination with PT-OT once a day for 5 days.
      Assessments will be done about 3 days and 7 days after the end of the experimental treatment
      by investigators who are blinded to the intervention. Patients are also blinded as to whether
      they are receiving real or sham tDCS. We hypothesize that real tDCS applied to the motor
      regions in combination with PT-OT results in a subsequent improvement in motor function of
      the recovering hand over sham tDCS in combination with PT-OT.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2006</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fugl-Meyer Assessment of Upper Extremity Motor Impairment</measure>
    <time_frame>Baseline Assessment; 3 days after 5 treatment days; 7 days after 5 treatment days</time_frame>
    <description>This scale goes from 0 to 66 (max). Higher values are considered to be a better outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wolf-Motor-Function-Test</measure>
    <time_frame>Baseline Assessment; 3 days after 5 treatment days; 7 days after 5 treatment days</time_frame>
    <description>The Wolf-Motor-Function-Test (time) is the average time in seconds taken to perform each of 15 functional tasks ranging in difficulty from putting one's forearm on a table to stacking checkers. Participants are given 120 seconds to perform a task and if they fail, they are scored 120 for that task,&quot; or similar as accurate. The average time in seconds is then log10 transformed.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Stroke</condition>
  <condition>Cerebrovascular Accident</condition>
  <condition>CVA</condition>
  <condition>Acute Stroke</condition>
  <condition>Acute Cerebrovascular Accident</condition>
  <condition>Apoplexy</condition>
  <arm_group>
    <arm_group_label>Real-tDCS + PT-OT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each subject will receive up to 5 days of traditional physical-occupational therapy for at least 1 hour per day in the stroke recovery laboratory in combination with real transcranial direct current stimulation (tDCS) over the motor region for up to 30 min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham-tDCS + PT-OT</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Each subject will receive up to 5 days of traditional physical-occupational therapy for at least 1 hour per day in the stroke recovery laboratory in combination with sham (pretend) tDCS for up to 30 min. over the motor region.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Real Transcranial Direct Current Stimulation</intervention_name>
    <description>A direct current runs between two electrode positions and affects the excitability of the underlying brain tissue</description>
    <arm_group_label>Real-tDCS + PT-OT</arm_group_label>
    <other_name>Non-invasive brain stimulation</other_name>
    <other_name>Brain stimulation</other_name>
    <other_name>Enhancing stroke recovery</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham Transcranial Direct Current Stimulation</intervention_name>
    <description>A sham current runs between two electrode positions and might affect the underlying brain tissue.</description>
    <arm_group_label>Sham-tDCS + PT-OT</arm_group_label>
    <other_name>Non-invasive brain stimulation</other_name>
    <other_name>Brain stimulation</other_name>
    <other_name>Enhancing stroke recovery</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  First time clinical ischemic stroke or cerebrovascular accident

          -  At least 5 months out from first ischemic stroke prior to study enrollment

        Exclusion Criteria:

          -  More than 1 stroke (older strokes)

          -  Significant pre-stroke disability

          -  A terminal medical illness or disorder with survival of less than 1 year

          -  Co-existent major neurological or psychiatric diseases (e.g., epilepsy)

          -  Use of psychoactive drugs/medications - such as antidepressants,antipsychotic,
             stimulating agents

          -  Active participation in other stroke recovery trials testing interventions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gottfried Schlaug, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Deaconess Medical Center / Harvard Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center / Harvard Medical School</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Vines BW, Nair D, Schlaug G. Modulating activity in the motor cortex affects performance for the two hands differently depending upon which hemisphere is stimulated. Eur J Neurosci. 2008 Oct;28(8):1667-73. doi: 10.1111/j.1460-9568.2008.06459.x.</citation>
    <PMID>18973584</PMID>
  </reference>
  <reference>
    <citation>Vines BW, Cerruti C, Schlaug G. Dual-hemisphere tDCS facilitates greater improvements for healthy subjects' non-dominant hand compared to uni-hemisphere stimulation. BMC Neurosci. 2008 Oct 28;9:103. doi: 10.1186/1471-2202-9-103.</citation>
    <PMID>18957075</PMID>
  </reference>
  <reference>
    <citation>Nair DG, Hutchinson S, Fregni F, Alexander M, Pascual-Leone A, Schlaug G. Imaging correlates of motor recovery from cerebral infarction and their physiological significance in well-recovered patients. Neuroimage. 2007 Jan 1;34(1):253-63. Epub 2006 Oct 27.</citation>
    <PMID>17070707</PMID>
  </reference>
  <reference>
    <citation>Vines BW, Nair DG, Schlaug G. Contralateral and ipsilateral motor effects after transcranial direct current stimulation. Neuroreport. 2006 Apr 24;17(6):671-4.</citation>
    <PMID>16603933</PMID>
  </reference>
  <results_reference>
    <citation>Lindenberg R, Renga V, Zhu LL, Nair D, Schlaug G. Bihemispheric brain stimulation facilitates motor recovery in chronic stroke patients. Neurology. 2010 Dec 14;75(24):2176-84. doi: 10.1212/WNL.0b013e318202013a. Epub 2010 Nov 10.</citation>
    <PMID>21068427</PMID>
  </results_reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2008</study_first_submitted>
  <study_first_submitted_qc>November 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2008</study_first_posted>
  <results_first_submitted>April 14, 2017</results_first_submitted>
  <results_first_submitted_qc>June 10, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">July 11, 2017</results_first_posted>
  <last_update_submitted>June 10, 2017</last_update_submitted>
  <last_update_submitted_qc>June 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beth Israel Deaconess Medical Center</investigator_affiliation>
    <investigator_full_name>Gottfried Schlaug</investigator_full_name>
    <investigator_title>Associate Professor of Neurology; Staff Neurologist</investigator_title>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Ischemia</keyword>
  <keyword>Infarction</keyword>
  <keyword>Cerebrovascular Disorder</keyword>
  <keyword>Central Nervous System Diseases</keyword>
  <keyword>Brain Infarction</keyword>
  <keyword>Brain Ischemia</keyword>
  <keyword>Rehabilitation</keyword>
  <keyword>Recovery</keyword>
  <keyword>Neurorehabilitation</keyword>
  <keyword>Plasticity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>We advertised in local media, on Craig's list, and informed neurology colleagues and rehabilitation specialists about our trial. Stroke patients had to be at least 5 months out from their stroke and had to have a moderate impairment in their upper extremity weakness.</recruitment_details>
      <pre_assignment_details>There were no significant events that occurred after participant enrollment, prior to assignment.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Real-tDCS + PT-OT</title>
          <description>Each subject will receive up to 5 days of traditional physical-occupational therapy for at least 1 hour per day in the stroke recovery laboratory in combination with real transcranial direct current stimulation (tDCS) over the motor region for up to 30 min.
Real Transcranial Direct Current Stimulation: A direct current runs between two electrode positions and affects the excitability of the underlying brain tissue</description>
        </group>
        <group group_id="P2">
          <title>Sham-tDCS + PT-OT</title>
          <description>Each subject will receive up to 5 days of traditional physical-occupational therapy for at least 1 hour per day in the stroke recovery laboratory in combination with sham (pretend) tDCS for up to 30 min. over the motor region.
Sham Transcranial Direct Current Stimulation: A sham current runs between two electrode positions and might affect the underlying brain tissue.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Real-tDCS + PT-OT</title>
          <description>Each subject will receive up to 5 days of traditional physical-occupational therapy for at least 1 hour per day in the stroke recovery laboratory in combination with real transcranial direct current stimulation (tDCS) over the motor region for up to 30 min.
Real Transcranial Direct Current Stimulation: A direct current runs between two electrode positions and affects the excitability of the underlying brain tissue</description>
        </group>
        <group group_id="B2">
          <title>Sham-tDCS + PT-OT</title>
          <description>Each subject will receive up to 5 days of traditional physical-occupational therapy for at least 1 hour per day in the stroke recovery laboratory in combination with sham (pretend) tDCS for up to 30 min. over the motor region.
Sham Transcranial Direct Current Stimulation: A sham current runs between two electrode positions and might affect the underlying brain tissue.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.7" spread="14.7"/>
                    <measurement group_id="B2" value="55.8" spread="12.9"/>
                    <measurement group_id="B3" value="58.7" spread="13.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fugl-Meyer Assessment of Upper Extremity Motor Impairment</title>
        <description>This scale goes from 0 to 66 (max). Higher values are considered to be a better outcome.</description>
        <time_frame>Baseline Assessment; 3 days after 5 treatment days; 7 days after 5 treatment days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Real-tDCS + PT-OT</title>
            <description>Subjects are receiving real tDCS in a dual configuration centered over the motor region on both hemispheres for 30 minutes while they are also receiving PT-OT for 60 minutes total.</description>
          </group>
          <group group_id="O2">
            <title>Sham-tDCS + PT-OT</title>
            <description>Subjects are receiving sham tDCS in a dual configuration centered over the motor region on both hemispheres for 30 minutes while they are also receiving PT-OT for 60 minutes total.</description>
          </group>
        </group_list>
        <measure>
          <title>Fugl-Meyer Assessment of Upper Extremity Motor Impairment</title>
          <description>This scale goes from 0 to 66 (max). Higher values are considered to be a better outcome.</description>
          <units>units on a scale [0-66]</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-treatment (Baseline)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.2" spread="13.3"/>
                    <measurement group_id="O2" value="39.8" spread="11.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-treatment1 (3 days after 5 days of treatment)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.8" spread="12.3"/>
                    <measurement group_id="O2" value="41.0" spread="11.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-treatment2 (7 days after 5 days of treatment)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.3" spread="11.5"/>
                    <measurement group_id="O2" value="40.9" spread="11.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Wolf-Motor-Function-Test</title>
        <description>The Wolf-Motor-Function-Test (time) is the average time in seconds taken to perform each of 15 functional tasks ranging in difficulty from putting one's forearm on a table to stacking checkers. Participants are given 120 seconds to perform a task and if they fail, they are scored 120 for that task,&quot; or similar as accurate. The average time in seconds is then log10 transformed.</description>
        <time_frame>Baseline Assessment; 3 days after 5 treatment days; 7 days after 5 treatment days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Real-tDCS + PT-OT</title>
            <description>Subjects are receiving real tDCS in a dual configuration centered over the motor region on both hemispheres for 30 minutes while they are also receiving PT-OT for 60 minutes total.</description>
          </group>
          <group group_id="O2">
            <title>Sham-tDCS + PT-OT</title>
            <description>Subjects are receiving sham tDCS in a dual configuration centered over the motor region on both hemispheres for 30 minutes while they are also receiving PT-OT for 60 minutes total.</description>
          </group>
        </group_list>
        <measure>
          <title>Wolf-Motor-Function-Test</title>
          <description>The Wolf-Motor-Function-Test (time) is the average time in seconds taken to perform each of 15 functional tasks ranging in difficulty from putting one's forearm on a table to stacking checkers. Participants are given 120 seconds to perform a task and if they fail, they are scored 120 for that task,&quot; or similar as accurate. The average time in seconds is then log10 transformed.</description>
          <units>units on a scale (log(sec))</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-treatment (baseline)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.87" spread="0.55"/>
                    <measurement group_id="O2" value="0.83" spread="0.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-treatment1 (3 days after 5 days of treatment)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.74" spread="0.49"/>
                    <measurement group_id="O2" value="0.79" spread="0.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-treatment2 (7 days after 5 days of treatment)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.73" spread="0.49"/>
                    <measurement group_id="O2" value="0.78" spread="0.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Over the 5 days of experimental treatment and during the 1 week follow-up.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Real-tDCS + PT-OT</title>
          <description>Subjects are receiving real tDCS in a dual configuration centered over the motor region on both hemispheres for 30 minutes while they are also receiving PT-OT for 60 minutes total.</description>
        </group>
        <group group_id="E2">
          <title>Sham tDCS + PT-OT</title>
          <description>Subjects are receiving sham tDCS in a dual configuration over both motor regions for 30 minutes while they are also receiving PT-OT for 60 minutes</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Gottfried Schlaug, MD, PhD</name_or_title>
      <organization>Beth Israel Deaconess Medical Center</organization>
      <phone>617-632-8917</phone>
      <email>gschlaug@bidmc.harvard.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

